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LTHOUGH MORTALITY RATES
for acute myocardial infarction (MI) and coronary heart disease (CHD) have declined in the United States since the 1970s, [1] [2] [3] [4] both death certificate data and evidence from 4 US communities suggest a steeper decline in acute CHD mortality between 2000 and 2008 for whites than for blacks, widening a longstanding disparity. 5, 6 Furthermore, data from Kaiser Permanente suggested that hospitalizations for MI decreased between 2002 and 2007, 7 but more so for whites than for blacks. Neither death certificate data nor health plan data permit examination of incident events. 5, [8] [9] [10] Two other major secular trends may influence contemporary estimates of incident CHD. First, statins have come into wide use over the past 10 years, 11 lowering incidence rates. Second, cardiac troponin assays have become increasingly sensitive and very small amounts of myocardial necrosis are now routinely detected. Even very small non-ST-elevation MIs (NSTEMIs), with peak troponin level of less than 0.5 µg/L, may confer similar long-term risks as larger MIs. [12] [13] [14] However, very small NSTEMIs have only recently been included in studies of MI event rates, resulting in higher reported MI incidence rates. The overall effect of these secular trends on estimates of CHD incidence and racial disparities is unclear.
We analyzed data from the national Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort with 3 objectives: (1) to examine racial and sex differences in incident total CHD, fatal CHD, and nonfatal CHD across race-sex groups, (2) to examine whether risk factors were associated with observed race-sex risk differences, and (3) to examine race-sex differences in participants with very small NSTEMIs.
METHODS
REGARDS Cohort Study Procedures
REGARDS is a prospective cohort study of 30 239 individuals examining regional and racial influences on stroke mortality. Details are described elsewhere 15, 16 ; briefly, participants were enrolled between 2003 and 2007 using commercially available lists and a combination of mail and telephone contacts to recruit English-speaking, communitydwelling adults aged 45 years or older, who were living in the continental United States. Race and sex were balanced by design, with oversampling from the Southeastern United States; the final cohort included 58% of participants who were women and 42% of participants who had black race. Race was self-reported. Baseline data collection included computerassisted telephone surveys assessing medical history and health status. Inhome examinations by trained health care professionals followed standardized, quality-controlled protocols to collect fasting blood and urine samples; electrocardiograms; blood pressure, height, and weight measurements; and medication use by pill bottle review. Blood and urine samples were centrally analyzed at the University of Vermont. Electrocardiograms were centrally analyzed at Wake Forest University.
Living participants or their proxies were followed up every 6 months by telephone with retrieval of medical records for reported hospitalizations. Deaths were detected by report of next of kin or through online sources (eg, Social Security Death Index) and the National Death Index. Proxies or next of kin were interviewed about the circumstances surrounding death, including the presence of chest pain. Death certificates and autopsy reports also were obtained to adjudicate cause of death.
For this study, individuals with prevalent CHD (self-report of MI or coronary revascularization procedure at baseline or evidence of prior MI on the baseline electrocardiogram)wereexcluded.Events through December 31, 2009 , were included in this analysis. At that time, 9.5% were lost to follow-up. The study protocol was reviewed and approved by the institutional review boards at the participating institutions and all participants provided informed consent.
Acute CHD Events
The CHD events were adjudicated by a teamofexpertswhousedpublishedguidelines. 17, 18 ForMI,medicalrecordswereexamined for the presence of signs or symptoms suggestive of ischemia; a rising and/ or falling pattern in cardiac troponin level or creatine phosphokinase-MB level over 6 or more hours with a peak level greater than twice the upper limit of normal (diagnostic cardiac enzymes); and electrocardiogramchangesconsistentwithischemia or MI, guided by the Minnesota code andclassifiedasevolvingdiagnostic,positive, nonspecific, or not consistent with ischemia. 19, 20 DefiniteMIswerethosewith diagnosticenzymesorelectrocardiogram. ProbableMIswerethosewithelevatedbut not diagnostic (ie, equivocal) enzymes with a positive but not diagnostic electrocardiogram; or, if enzymes were missing, with a positive electrocardiogram in the presence of ischemic signs or symptoms. Only definite or probable MIs were included as events in this study. The highest and lowest levels of troponin and upper limits of normal for the hospital's assay also were recorded. Myocardial infarction that was adjudicated to have been caused by an invasive procedure was classified as procedure-related.
Because there is no widely accepted approach to defining very small NSTEMI, we examined publicly available upper limits of normal for commercially available troponin assays 21 and conservatively used 0.5 µg/L as the threshold of peak troponin to define very small NSTEMI, which is a level above twice the upper limit of all but 1 assay. Other MIs, including the 9 without troponin level available, were considered typical MIs. Elective and urgent coronary revascularization procedures were not included in the main analysis because their use differs by race. [22] [23] [24] [25] [26] [27] [28] [29] [30] For fatal events, the medical history, hospital records, interviews with next of kin or proxies, and death certificate or National Death Index data were reviewed to adjudicate the cause of death, with definite or probable CHD death used in the analysis (an expanded definition appears in the eAppendix at http://www.jama.com). 17 Cases were assigned to 2 adjudicators and disagreements were adjudicated by committee. The test for agreement between adjudicators yielded a level greater than 0.80 for the presence of definite or probable MI or definite or probable acute CHD death.
The 3 main end points examined were a composite of fatal (definite or probable CHD death) or nonfatal CHD (definite or probable MI), and fatal and nonfatal CHD events, separately. Within nonfatal CHD events, we also examined very small NSTEMI and typical MI separately.
Covariates
Age, race, sex, income, education, and smoking status were self-reported. Annual income was dichotomized at less than $20 000 and education was dichotomized at less than a high school diploma. Smokers were defined as having smoked at least 100 cigarettes in their lifetime and smoking now, even if just occasionally. Use of antihypertensive and statin medications was based on selfreport and pill bottle review.
The biometrics used in this analysis included body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) and blood pressure. Participants had their height and weight measured using a standardized protocol during the in-home visit. Body mass index was modeled as a continuous measure. Blood pressure was obtained using an aneroid sphygmomanometer after a seated rest of 5 minutes with both feet on the floor. 16 Two measures were obtained following a standardized protocol and averaged. Systolic blood pressure was modeled as a continuous variable.
Blood and urine markers included levels of total cholesterol, high-density lipoprotein (HDL) cholesterol, fasting glucose, high-sensitivity C-reactive protein (CRP), serum creatinine, and urinary albumin and creatinine from a spot urine specimen. Total and HDL cholesterol levels were modeled as continuous variables. Diabetes was classified as present if fasting glucose level was 126 mg/dL or greater (nonfasting glucose level: Ն200 mg/dL; n=229) or if patient reported taking diabetes medications. Highsensitivity CRP was log-transformed and modeled as a continuous variable. Estimated glomerular filtration rate (GFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation. 31 Urinary albumin and creatinine levels were used to define the ratio of albumin to creatinine.
Analysis
Age-standardizedincidenceratesper1000 person-yearswerecalculatedforeachrace and sex group for each end point. Sexstratified Cox proportional hazards models were constructed to estimate the hazardratios(HRs)forblackscomparedwith whites for incident events for the 3 end points (total CHD, fatal CHD, and nonfatal CHD). The assumptions of proportionalityweremetandtherewerenotimedependent variables. Individuals were censored at the time of their event, death, or the end of follow-up. Models were constructedincrementallytoexaminechanges in HR as covariates were added. Model 1 adjusted for age and region (stroke belt, stroke buckle, or other parts of the continental United States because the REGARDS study oversampled residents of the stroke belt and stroke buckle).
Model 2 added income and education to model 1 covariates. Model 3 added Framingham risk factors (levels of total and HDL cholesterol, smoking status, systolic blood pressure, and diabetes status) and use of statin or antihypertensive medication to model 2 covariates. Model 4 added BMI,estimatedGFR,andlog-transformed ratio of albumin to creatinine, and highsensitivity CRP to model 3 covariates. Missing covariates were imputed using chained equations with 5 data sets. 32, 33 We calculated the age-standardized incidence of very small NSTEMI and typical MI per 1000 person-years for each race and sex group. The HRs for blacks compared with whites for typical and very small NSTEMI were estimated from sex-stratified Cox proportional hazards models with identical incremental adjustment as those described above for the main analysis.
Sensitivity analyses examined the effect of including elective and urgent percutaneouscoronaryrevascularizationprocedures and coronary artery bypass graft surgery in the analysis as incident events. After including these procedures, the agestandardized rates for total incident CHD, fatal CHD, and nonfatal CHD and Cox proportional hazard models (as described above) were calculated for each race and sex group. Because blacks have a shorter life expectancy than whites, we also examined whether all-cause mortality among blacks was a competing risk for nonfatal CHD by entering all-cause mortality as a competing risk to the fully adjustedmodels.Also,weexaminedtherole of MIs complicating coronary interventionsandothersurgicalproceduresforthe end points. Statistical significance for all analyses was a P value of less than .05. Analyses were conducted using SAS version 9.2 (SAS Institute Inc) and Stata version 11 (StataCorp).
RESULTS
Sample Characteristics
After excluding 5314 individuals with baseline CHD and 426 without followup,thestudysampleincluded24 443par-ticipants(TABLE1).Blacksandwhiteshad a similar mean age, but blacks had less Figure) .
Risks for CHD
For total CHD, the age-and regionadjusted HR for black men compared with white men was 1.15 (95% CI, 0.94-1.41) (model 1) and in the fully adjusted model it was 0.87 (95% CI, 0.69-1.08; model 4) (TABLE 3). Among women, the age-and region-adjusted HR for total CHD for blacks vs whites was 1.48 (95% CI, 1.15-1.90) and in the fully adjusted model it was 0.90 (95% CI, 0.68-1.20).
For fatal CHD, the age-and regionadjusted HR for black men compared with white men was 2.18 (95% CI, 1.55-3.06) and in the fully adjusted model it was 1.34 (95% CI, 0.91-1.96). Among women, the age-and region-adjusted HR for fatal CHD for blacks vs whites was 1.93 (95% CI, 1.23-3.03) and in the fully adjusted model it was 1.14 (95% CI, 0.69-1.99) ( Table 3) .
For nonfatal CHD, the age-and region-adjusted HR for black men compared with white men was 0.81 (95% CI, 0.63-1.06) and in the fully adjusted model it was 0.68 (95% CI, 0.51-0.91). Among women, the age-and regionadjusted HR for nonfatal CHD for blacks vs whites was 1.31 (95% CI, 0.97-1.77) and in the fully adjusted model it was 0.81 (95% CI, 0.58-1.15) ( Table 3 ).
Role of Very Small NSTEMI
Very small NSTEMI comprised 31.3% of nonfatal CHD events; there were 33 (40.2%) among black men, 47 (24.6%) among white men, 35 (39.8%) among black women, and 24 (28.9%) among white women (Table 2) . Incidence rates for typical MI were lower for black men than for white men, but rates for very small NSTEMI were similar (eFigure 1 at http://www.jama.com). In contrast, incidence rates for typical MI were similar for black women and white women, but incidence rates for very small NSTEMI were higher for black women than for white women.
The HRs for typical MI for blacks vs whites were similar to the overall nonfatal CHD results for both men and women (TABLE 4). The HR for very small NSTEMI was not statistically different for black men vs white men, but black women had a higher ageadjusted HR for very small NSTEMI vs white women, which became nonsignificant with full adjustment. 
Sensitivity Analyses
Including coronary revascularization procedures substantially and disproportionately increased the age-standardized incidence rates for whites vs blacks. There were 10 procedure-related MIs among black men and 23 among white men; the results including procedurerelated MIs were almost identical to those that did not include these events.
COMMENT
In the REGARDS study, black men and black women had twice the agestandardized rate of fatal incident CHD compared with white men and white women. This increased risk was associated with racial differences in CHD risk factors, which were more prevalent among black men and women compared with white men and women. A marked sex difference was present for nonfatal acute CHD: black men had a lower risk of presenting with incident nonfatal acute MI than white men, but black women had a higher risk than white women. The low risk in black men remained present in the fully adjusted models, but the excess risk observed among black women was entirely attenuated after accounting for their higher cardiovascular disease risk factor burden. The high risk of presenting with death as the first manifestation of CHD among black men and women, which is associated with excess burden of cardiovascular disease risk factors, is similar to past reports [4] [5] [6] [7] and demonstrates little evidence of progress toward eliminating this disparity.
The incidence rates we observed were consistent with other reports of continued downward trends in MI and acute 3 covariates plus body mass index, estimated glomerular filtration rate of less than 60 mL/min, log-transformed high-sensitivity C-reactive protein, and log-transformed albumin-to-creatinine ratio. 3 covariates, body mass index, estimated glomerular filtration rate of less than 60 mL/min, logtransformed high-sensitivity C-reactive protein, and log-transformed albumin-to-creatinine ratio.
CHD mortality. There are relatively few biracialcohortsthatprovideincidencedata in the United States. Incidence rates for CHD from the Atherosclerosis Risk in Communities(ARIC)studyweresubstantially higher per 1000 person-years in the 1990s than in our study (10.6 for black men, 12.5 for white men, 5.1 for black women, and 4.0 for white women). 34 Of note,coronaryrevascularizationswereincluded as CHD events in that report. The use of these procedures has increased dramatically since that time, albeit with some recentdecreases, 22 andweobservedlower revascularization use among black vs white REGARDS participants. More recently, the ARIC surveillance study reporteddeclinesinCHDdeathwithouthistory of MI as well as first MI from 1987 through 2008, revealing larger declines for whites than for blacks, with the lowest decline found in black men and an increaseinfirstMIamongblackmen. 5 These results support the continued disparities in CHD we observed.
The racial and sex differences in fatal vs nonfatal acute CHD incidence rates that we observed are, to our knowledge, new. In the ARIC study, the incidence of overall CHD was similar for black and white men and for black and white women, but nonfatal and fatal events were not reported separately. 34 A recent analysis of pooled ARIC and Cardiovascular Health Study data compared risks of sudden cardiac death (SCD) and non-SCD CHD (nonfatal CHD, including revascularization procedures, and fatal CHD judged not to be SCD) over 14 years ending in 2002. 35 This study reported a HR of 1.81 (95% CI, 1.31-2.49) for SCD for blacks compared with whites and a HR of 0.76 (95% CI, 0.67-0.86) for non-SCD. While these categories are not directly comparable with ours, the results are generally concordant. Our more recent results, taken together with prior studies, suggest there has been disappointingly little progress in lowering the excess risk of death at first clinical presentation of acute CHD among blacks.
To our knowledge, previous reports have not found the lower risk of incident nonfatal CHD among black men that we described. The additional analyses we conducted did not support that all-cause mortality was a competing risk, or that procedure-related MI, which potentially could have inflated nonfatal CHD in white men, contributed substantially. The low risk was seen only for typical MIs but not very small NSTEMIs. Additional studies are needed to confirm these findings.
The role of very small NSTEMI in the incidence of acute CHD is an emerging phenomenon. Numerous reports confirm the long-term risks associated with very small NSTEMIs, and experts including the European Society of Cardiology, the American College of Cardiology Federation, the American Heart Association, and the World Heart Federation recommend classifying such events as MIs. 14, 18, [36] [37] [38] [39] [40] The large proportion of very small NSTEMIs suggests that comparisons of contemporary with past incidence rates will be complicated, especially for studies of racial disparities if our findings across race and sex groups are confirmed in other studies. In addition, the optimal threshold for defining very small NSTEMI is not clear; past reports that included estimates of the incidence of very small NSTEMI relative to typical MIs used varying definitions of this entity. 14, 38, 39, 41 We selected a conservative threshold but other thresholds may be reasonable, and consensus on how to define very small NSTEMI across epidemiological studies may be warranted, along with consensus on how to handle very small NSTEMI for comparisons with past studies.
Limitations of this study include its observational design and attendant cautions about drawing causal inferences. The REGARDS cohort was not designed as a surveillance study; thus, we likely underestimated incidence for nonfatal CHD events but not for fatal CHD events, which have more complete ascertainment. Although the REGARDS cohort has wide reach, participants in any research study may differ from the general population, affecting generalizability. Some of our covariates were self-reported, which carries limitations. Future analyses will permit more in-depth exploration of very small NSTEMIs.
Strengths of this study include its national scope and unique in-home data collection, facilitating participation from residents of geographic areas beyond driving distance of large research institutions. The large number of geographically dispersed black and white participants is another notable strength, as is the contemporaneous nature of the cohort, with ongoing follow-up and rigorous adjudication of events using published guidelines, including conducting interviews with next of kin.
CONCLUSIONS
Similar incidence rates of total CHD among men obscured marked racial differences in fatal and nonfatal CHD. Fatal CHD risk was higher among black men and associated with known risk factors, but nonfatal CHD risk was lower with and without risk factor adjustment. In contrast, black women had higher rates of total, fatal, and nonfatal CHD, with higher risks attenuated by known risk factors. Excess risk factor burden among black men and women continues to be a major public health challenge, along with their high risk for death as the presentation of CHD. Increased emphasis on optimizing well-established CHD risk factors among blacks could potentially reduce these disparities.
